文献速递冠心病心力衰竭与心肌病

血管外肺水指数指导容量管理改善心原性休克预后

[Beneficial effects of extravascular lung water index-guided volum management in patients with cardiogenic shock].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2024-01-01

单中心前瞻性队列研究纳入200例心原性休克患者,经倾向性评分1∶1匹配分为EVLWI组和对照组。EVLWI指导容量管理组30天全因死亡率、心原性死亡率及心衰再入院率均低于对照组,且基线EVLWI可预测30天全因死亡,最佳切点为>10.3 ml/kg。

要点

  • EVLWI指导容量管理可降低心原性休克患者30天全因死亡、心原性死亡及心衰再入院率。
  • 基线EVLWI预测30天全因死亡的AUC为0.84,最佳切点>10.3 ml/kg。
  • 无论缺血或非缺血性病因、是否使用正性肌力药物,EVLWI指导均与30天全因死亡率降低相关。

核心结论

  • EVLWI指导的容量管理有利于优化心原性休克的治疗决策,改善临床预后和心功能。

研究设计与样本

  • 单中心前瞻性队列研究,纳入2022年7月至2023年12月于同济大学附属东方医院心内科就诊的心原性休克患者200例,经1∶1倾向性评分匹配分为EVLWI组和对照组各100例。
  • 对照组由主诊医生基于临床表现、生化测定和血压指标等决定容量管理策略;EVLWI组采用脉搏指示连续心排血量技术监测血管外肺水状态,并结合常规指标制订容量管理方案。

主要发现

  • EVLWI组30天全因死亡率16%(16/100)低于对照组42%(42/100),log-rank P<0.01。
  • EVLWI组30天心原性死亡率14%(14/100)低于对照组34%(34/100),log-rank P<0.01。
  • EVLWI组30天心力衰竭再入院率4%(4/100)低于对照组12%(12/100),log-rank P=0.03。
  • EVLWI组中死亡患者基线EVLWI为(15.99±6.47)ml/kg,高于存活者的(9.75±2.55)ml/kg,P<0.01。
  • 基线EVLWI预测30天全因死亡的AUC为0.84(95%CI:0.75~0.94,P<0.01),最佳切点为>10.3 ml/kg;基线中心静脉压无预测价值(AUC=0.54,95%CI:0.40~0.69,P=0.60)。

关键数值与推荐

  • 基线EVLWI预测心原性休克患者治疗后30天全因死亡的AUC为0.84(95%CI:0.75~0.94,P<0.01)。
  • EVLWI>10.3 ml/kg是预测30天全因死亡的最佳切点值。
  • 亚组分析显示,缺血或非缺血性病因、使用或不使用正性肌力药物的患者中,EVLWI指导容量管理均使30天全因死亡率显著减低(P均<0.05)。
  • EVLWI组随着血流动力学参数优化,左心室射血分数升高,血清N末端B型利钠肽原、肌酐、谷丙转氨酶和乳酸水平降低(P均<0.05)。

临床怎么用

  • 对心原性休克患者,可考虑采用PiCCO监测EVLWI并结合常规指标指导容量管理。
  • 基线EVLWI>10.3 ml/kg提示30天全因死亡风险较高,可作为风险分层参考。
  • 中心静脉压对预测30天全因死亡无价值,不宜单独用于容量管理决策。

局限性

  • 本研究为单中心前瞻性队列研究,样本量200例,结果外推需谨慎。
  • 原文未报告盲法、随访丢失及具体混杂因素控制等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the role of volume management guided by extravascular lung water index(EVLWI) in improving the clinical outcomes and cardiac function for patients with cardiogenic shock. Methods: This study was a single-center, prospective cohort study. Patients with cardiogenic shock admitted to the Department of Cardiovascular Medicine, Shanghai East Hospital from July 2022 to December 2023 were enrolled. Patients were matched 1∶1 by propensity score and divided into EVLWI group and control group. In the control group, the volume management strategy was determined by the attending physician based mainly on conventional factors, including clinical features, biochemical assessments, and certain blood pressure measurements. In EVLWI group, the volume management plan was formulated by integrating conventional factors with EVLWI derived from pulse index continuous cardiac output (PiCCO) monitoring. Baseline clinical data, in-hospital treatment, and hemodynamic data were collected. Major adverse cardiovascular events and cardiac function related parameters were compared at 30 d after treatment between the two groups. Baseline EVLWI levels were compared between the non-survivors and the survivors in the EVLWI group. The receiver operating characteristic curve was plotted to assess the accuracy of baseline EVLWI and central venous pressure in predicting all-cause mortality at 30 d after treatment in patients with cardiogenic shock, and subgroup analysis was performed according to ischemic/non-ischemic etiology and with/without use of inotropic drugs. Kaplan-Meier curve was used for survival analysis, with log-rank tests comparing all-cause mortality, cardiac death, and readmission rate for heart failure at 30 d after treatment. Results: A total of 200 patients with cardiogenic shock were enrolled, aged (71.35±12.82) years, 144(72%) males, EVLWI group and control group 100 patients each. Compared with the control group, EVLWI group had lower all-cause mortality (16%(16/100) vs. 42%(42/100), log-rank P<0.01), cardiac death (14%(14/100) vs. 34%(34/100), log-rank P<0.01), and readmission rate for heart failure (4%(4/100) vs. 12%(12/100), log-rank P=0.03) at 30 d after treatment. Subgroup analysis showed that EVLWI-guided volume management was associated with lower all-cause mortality at 30 d after treatment in patients with cardiogenic shock of ischemic or non-ischemic etiology and with or without inotropic drugs (all P<0.05). In EVLWI group, baseline EVLWI levels were higher in non-survivors than those in survivors [(15.99±6.47) ml/kg vs.(9.75±2.55) ml/kg, P<0.01]. The baseline EVLWI could predicting all-cause mortality at 30 d after treatment in patients with cardiogenic shock, with an area under the receiver operating characteristic curve of 0.84 (95%CI: 0.75-0.94, P<0.01), while the baseline central venous pressure had no predicting value (AUC=0.54, 95%CI: 0.40-0.69, P=0.60). The optimal cutoff value of EVLWI in pridicting all-cause mortality at 30 d after treatment in patients with cardiogenic shock was >10.3 ml/kg. With the optimization of hemodynamic parameters, left ventricular ejection fraction was improved in EVLWI group, and serum levels of N-terminal pro-brain natriuretic peptide, creatinine, alanine aminotransferase and lactic acid were decreased (all P<0.05). Conclusion: EVLWI-guided volume management exerts a beneficial effect on therapeutic decision-making and improves clinical outcomes and cardiac function in patients with cardiogenic shock. 目的: 评估血管外肺水指数(EVLWI)指导容量管理对于改善心原性休克患者的临床预后和心功能的作用。 方法: 本研究为单中心前瞻性队列研究。纳入200例2022年7月至2023年12月于同济大学附属东方医院心内科就诊的心原性休克患者,经1∶1倾向性评分匹配分为EVLWI组和对照组。对照组由主诊医生基于临床表现、生化测定和血压指标等决定容量管理策略;EVLWI组采用脉搏指示连续心排血量技术监测血管外肺水状态,并结合上述指标制订容量管理方案。收集患者的基线临床资料、住院治疗情况及血流动力学数据。比较两组患者治疗后30 d主要不良心血管事件和心功能相关参数。比较EVLWI组中死亡和存活患者的基线EVLWI水平。绘制受试者工作特征曲线,评估基线EVLWI及中心静脉压预测心原性休克患者治疗后30 d全因死亡的准确性,并根据缺血/非缺血性病因、有/无使用正性肌力药物进行亚组分析。生存分析采用Kaplan-Meier曲线,采用log-rank法比较心原性休克患者治疗后30 d全因死亡、心原性死亡及心力衰竭再入院率。 结果: 纳入的200例心原性休克患者年龄为(71.35±12.82)岁,男性144例(72%),EVLWI组和对照组各100例。与对照组相比,EVLWI组患者治疗后30 d全因死亡率[16%(16/100)比42%(42/100),log-rank P<0.01]、心原性死亡率[14%(14/100)比34%(34/100),log-rank P<0.01]及心力衰竭再入院率[4%(4/100)比12%(12/100),log-rank P=0.03]均较低。亚组分析显示,无论缺血或非缺血性病因所致心原性休克,以及是否使用正性肌力药物的患者,EVLWI指导容量管理均使治疗后30 d全因死亡率显著减低(P均<0.05)。EVLWI组中死亡患者的基线EVLWI水平显著高于存活者[(15.99±6.47)ml/kg比(9.75±2.55)ml/kg,P<0.01]。基线EVLWI预测心原性休克患者治疗后30 d全因死亡的受试者工作特征曲线下面积为0.84(95%CI:0.75~0.94,P<0.01),EVLWI>10.3 ml/kg是预测的最佳切点值。而基线中心静脉压对预测心原性休克患者治疗后30 d全因死亡无价值(AUC=0.54,95%CI:0.40~0.69,P=0.60)。随着血流动力学参数的优化,EVLWI组左心室射血分数升高,血清N末端B型利钠肽原、肌酐、谷丙转氨酶和乳酸水平降低(P均<0.05)。 结论: EVLWI指导的容量管理有利于优化心原性休克的治疗,改善患者临床预后。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. You, Guo, Geng, et al. [Beneficial effects of extravascular lung water index-guided volum management in patients with cardiogenic shock]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 39289999. doi:10.3760/cma.j.cn112148-20240213-00093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。